Saku Biosciences, Inc: Building the next generation of biomanufacturing infrastructure to make food, industrial materials, and health products scalable and sustainable.
Market:
Global demand for sustainable food and ingredients is projected to exceed $700B by 2030, yet current biomanufacturing strains are inefficient, costly, and fragile. Producers face bottlenecks in yield, reliability, and scalability. Saku’s platform enables higher-performing strains, unlocking faster commercialization and reducing costs across food, agbio, and pharma markets.

Technology:
Saku’s PicoShell technology screens millions of microbial strains in parallel, selecting the highest performers for yield, resilience, and quality. Unlike traditional methods that are slow and low-throughput, PicoShells allow continuous growth and real-time functional screening, accelerating strain engineering from years to months. This unlocks more sustainable production of proteins, lipids, and other high-value ingredients.
Advantages:
- Ultra-high throughput screening
- Real growth environment fidelity
- Faster commercialization timelines
- Lower cost of production
- Broad cross-industry applications
Development Stage:
- Prototype (advanced laboratory validation in progress)
Patents Issued:
- WO2022031857A2 – Biodegradable Hollow Particle Technology
Filed by Mark van Zee, this international (PCT) patent application covers biodegradable hollow particles—key components of our PicoShell™ platform—designed for high-throughput microbial screening with improved environmental compatibility. - Role in Our Platform
These hollow, biodegradable particles are the core innovation behind real-time, scalable strain selection—combining environmental safety and functional reliability. We have an exclusive license to leverage this technology for our biomanufacturing initiatives.
Select Press Releases/Publications/Presentations:
- Published in Proceedings of the National Academy of Sciences (PNAS), the study demonstrates PicoShells as picoliter-scale porous hydrogel containers with a hollow inner cavity and permeable outer shell. This design lets cells grow in production-like environments—such as bioreactors or shaking flasks—while remaining compatible with standard flow cytometry for high-throughput sorting.
Contact:
- Website: Coming soon!
- Phone: 310-975-4759
- Email: mark@sakubio.com
- LinkedIn: https://www.linkedin.com/company/101763173/ | https://www.linkedin.com/in/mark-van-zee-089910154/
- Anaco
- CDR3 Therapeutics, Inc.
- Dalton Bioanalytics
- Diatom Biolab
- Eximius Diagnostics
- Giant BioSystems
- Hikari Medical Technologies
- ImmunoVec
- MedStat AI Inc.
- Mervyn's Petcare, Inc.
- Meteor Biotech, LLC
- My Block Skin, Inc.
- Nanomega CryoAI
- NEXT-TFX, Inc.
- Paralos Bioscience Inc.
- Pelage Pharmaceuticals
- Pluto Immunotherapeutics
- Protean Research, Inc.
- Purpose Bio
- RaizDx
- RiboForge
- Saku Biosciences, Inc.
- SolGrapH, Inc.
- Sorriso Pharmaceuticals
- Thermeutics, Inc.
- Veergen, Inc.
- Yuyu Bio, Inc.